In a landmark ruling, the U.S. Supreme Court ensures that health insurers must continue to cover preventive services like cancer screenings and HIV medications at no cost to patients. This decision safeguards vital health benefits amidst ongoing challenges to Obamacare.
In a controversial decision, the Supreme Court ruled that Medicaid patients cannot sue to receive health care from Planned Parenthood, allowing South Carolina to cut funding. This ruling has significant implications for reproductive health services across the country.
In a controversial 6-3 ruling, the Supreme Court has sided with South Carolina, allowing the state to defund Planned Parenthood and ruling that Medicaid patients cannot sue to choose their providers. This decision raises concerns about healthcare rights and reproductive services.
In a controversial ruling, the Supreme Court allows South Carolina to block Planned Parenthood from receiving federal Medicaid funds for non-abortion services, raising concerns over healthcare access and patients' rights.
A child in Greensboro tested positive for measles, prompting North Carolina hospitals to prepare for potential outbreaks. Experts warn of low vaccination rates and the contagious nature of the virus.
A groundbreaking study reveals that insulin resistance, measured by the triglyceride-glucose (TyG) index, can be a crucial indicator of rapid cognitive decline in Alzheimer's patients. Those with higher TyG levels face a fourfold increase in deterioration rates, prompting new intervention strategies.
A groundbreaking study reveals that a blood test can identify Alzheimer's patients at risk of rapid decline. Researchers highlight the importance of insulin resistance in accelerating cognitive impairment, opening doors for timely interventions.
A groundbreaking study has identified knee braces as the most effective treatment for osteoarthritis pain. While many therapies were tested, the simplicity of the knee brace shines through. But can patients be convinced to wear them?
A new study indicates that a single dose of psilocybin can alleviate depression for up to five years, offering hope for those with major depressive disorder. This groundbreaking research highlights the potential of psychedelics in mental health treatment.
A new phase 2 trial reveals that a single dose of psilocybin, combined with psychological support, significantly reduces depression in over half of cancer patients, lasting up to two years.
